We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · November 13, 2020

Regional Citrate vs Systemic Heparin in CRRT Patients

JAMA: The Journal of the American Medical Association


Additional Info

JAMA: The Journal of the American Medical Association
Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial
JAMA 2020 Oct 27;324(16)1629-1639, A Zarbock, M Küllmar, D Kindgen-Milles, C Wempe, J Gerss, T Brandenburger, T Dimski, B Tyczynski, M Jahn, N Mülling, M Mehrländer, P Rosenberger, G Marx, TP Simon, U Jaschinski, P Deetjen, C Putensen, JC Schewe, S Kluge, D Jarczak, T Slowinski, M Bodenstein, P Meybohm, S Wirtz, O Moerer, A Kortgen, P Simon, SM Bagshaw, JA Kellum, M Meersch

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading